Dietrich A Stephan - Net Worth and Insider Trading
Dietrich A Stephan Net Worth
The estimated net worth of Dietrich A Stephan is at least $48,387 dollars as of 2024-11-13. Dietrich A Stephan is the President and CEO, 10% Owner of NeuBase Therapeutics Inc and owns about 128,008 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $48,387. Details can be seen in Dietrich A Stephan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dietrich A Stephan has not made any transactions after 2020-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dietrich A Stephan
Dietrich A Stephan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dietrich A Stephan owns 1 companies in total, including NeuBase Therapeutics Inc (NBSE) .
Click here to see the complete history of Dietrich A Stephan’s form 4 insider trades.
Insider Ownership Summary of Dietrich A Stephan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-06-09 | director & 10 percent owner & President and CEO |
Dietrich A Stephan Latest Holdings Summary
Dietrich A Stephan currently owns a total of 1 stock. Dietrich A Stephan owns 128,008 shares of NeuBase Therapeutics Inc (NBSE) as of June 9, 2020, with a value of $48,387.
Latest Holdings of Dietrich A Stephan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2020-06-09 | 128,008 | 0.38 | 48,387 |
Holding Weightings of Dietrich A Stephan
Dietrich A Stephan Form 4 Trading Tracker
According to the SEC Form 4 filings, Dietrich A Stephan has made a total of 3 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 64 shares on June 9, 2020, which cost Dietrich A Stephan around $9,856.
Insider Trading History of Dietrich A Stephan
- 1
Dietrich A Stephan Trading Performance
GuruFocus tracks the stock performance after each of Dietrich A Stephan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dietrich A Stephan is 8.84%. GuruFocus also compares Dietrich A Stephan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dietrich A Stephan within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dietrich A Stephan's insider trading performs compared to the benchmark.
Performance of Dietrich A Stephan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.83 | | | | | |
| Relative Return to S&P 500(%) | 12.2 | | | | | |
Dietrich A Stephan Ownership Network
Ownership Network List of Dietrich A Stephan
Ownership Network Relation of Dietrich A Stephan
Dietrich A Stephan Owned Company Details
What does NeuBase Therapeutics Inc do?
Who are the key executives at NeuBase Therapeutics Inc?
Dietrich A Stephan is the director & 10 percent owner & President and CEO of NeuBase Therapeutics Inc. Other key executives at NeuBase Therapeutics Inc include 10 percent owner Symetryx Corp , 10 percent owner Barry Shiff , and 10 percent owner Aleta Shiff .
NeuBase Therapeutics Inc (NBSE) Insider Trades Summary
Over the past 18 months, Dietrich A Stephan made no insider transaction in NeuBase Therapeutics Inc (NBSE). Other recent insider transactions involving NeuBase Therapeutics Inc (NBSE) include a net sale of 428,444 shares made by Symetryx Corp ,
In summary, during the past 3 months, insiders sold 0 shares of NeuBase Therapeutics Inc (NBSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,520 shares of NeuBase Therapeutics Inc (NBSE) were sold and 61,076 shares were bought by its insiders, resulting in a net sale of 428,444 shares.
NeuBase Therapeutics Inc (NBSE)'s detailed insider trading history can be found in Insider Trading Tracker table.
NeuBase Therapeutics Inc Insider Transactions
Dietrich A Stephan Mailing Address
Above is the net worth, insider trading, and ownership report for Dietrich A Stephan. You might contact Dietrich A Stephan via mailing address: 213 Smithfield St, Pittsburgh Pa 15222.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
